The Company recorded expense of approximately $5.4 million and $15.6 million in the third quarter and nine months ended September 25, 2022, respectively, for its stock-based compensation plans in the condensed consolidated statements of income. Stock-based compensation expense of $7.0 million and $17.3 million was recorded in the third quarter and nine months ended September 26, 2021, respectively.

The Board approved various stock-based grants under the Company’s 2009 Omnibus Incentive Plan in the nine months ended September 25, 2022 totaling 237,069 shares in the aggregate at an average fair value of $64.73 at grant date for a total fair value at grant date of $15.3 million.

As of September 25, 2022, there was approximately $26.4 million of total unrecognized compensation cost related to stock-based compensation arrangements granted under incentive plans. That cost is expected to be recognized over a weighted-average period of 13.4 months.